Updated:
STEMLINE THERAPEUTICS INC
STEMLINE THERAPEUTICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001264587, and its reported...
Overview
STEMLINE THERAPEUTICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001264587, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-16, it reported net income of USD -76,817,225; total assets of USD 186,979,004 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- STEMLINE THERAPEUTICS INC
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- New York, NY, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001264587
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2019USD | — | -$76.8M | $187.0M | $13.6M | -$67.7M | |
| FY2018USD | $500,000 | -$85.0M | $63.5M | $9.4M | -$72.2M | |
| FY2017USD | — | -$67.8M | $67.0M | $4.8M | -$49.6M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| SC 13D | — | SC 13D | |
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| DEF 14A | DEF 14A | ||
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K | ||
| SC 13G | — | SCHEDULE 13G | |
| SC 13G | — | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | |
| SC 13G | — | SC 13G | |
| 10-Q | 10-Q | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research STEMLINE THERAPEUTICS INC in Altss
Track this company’s investors, transactions and relationships in Altss.